FMC-NA Names Joe Turk New President for Renal Therapies Group
Joseph (Joe) Turk succeeds Mark Constanzo, who recently retired, as the new President for the Fresenius Medical Care North America Renal Therapies Group, and will now oversee the renal products and pharmaceutical operations.
Read the full article » | Posted 08-12-2021
- Outset Medical Beat Q2 Wall Street Projections Posted 09-14-2021
- Fresenius Invests to Help Humacyte Develop Implantable Blood Vessels Posted 09-14-2021
- Diality Appoints Chief Business Officer Posted 08-12-2021
- Quanta Receives $245M Investment for SC+ Home HD System Posted 07-12-2021